E-Learning Center
Join Our Network
OncoFacts

Follow Imedex on Twitter

Register for an upcoming conference!

Phone: +1 (678) 242 0906
registration@imedex.com

The Management of Women with Chronic Immune Disorders in the Era of Biologics


Register Now

The Management of Women with Chronic Immune Disorders in the Era of Biologics

September 25, 2010

New York, New York

Continuing Medical Education

Purdue

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Purdue University College of Pharmacy and Imedex, LLC. Purdue University College of Pharmacy is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Purdue University College of Pharmacy designates this educational activity for a maximum 6.0 of AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.


American Academy of Dermatology

The Imedex, LLC’s Management of Women with Chronic Immune Disorders in the Era of Biologics (Program #36300) is recognized by the American Academy of Dermatology for 5.5 AAD Recognized Category 1 CME credits and may be used toward the AAD CME Award.


Who Should Attend

This activity is intended for gastroenterologists, endocrinologists, rheumatologists, dermatologists, obstetricians, internists, clinical researchers, and other persons in the healthcare community with an interest in the treatment and management of women of all ages with chronic immune diseases (CIDs) such as inflammatory bowel disease (IBD), rheumatoid arthritis (RA),
and psoriasis.


Objectives

After successful completion of this course, participants should be able to:

  • Discuss the challenges and controversies surrounding therapeutic considerations for biologics in women with chronic immune diseases including, optimal treatment algorithms and classes of agents
  • Comment on the prevalence of chronic immune diseases in women along with accompanying features, symptoms, complications, and special management considerations and how this affects quality of life
  • Describe how IBD affects the pediatric patient, especially pubescent females and how young age affects treatment options for CIDs
  • Assess the long-term risks of cardiovascular events in women with chronic immune disease and how the latest biologics may contribute to these risks
  • Identify how to adequately maintain proper health in women with chronic immune disease using the latest data and recommendations for vaccination, bone monitoring, and cancer screening
  • Analyze the influence of chronic immune disorders such as IBD, RA, spondyloarthopathy, and psoriasis on fertility and/or pregnancy and conversely how pregnancy affects the onset of CIDs

Eliza Chakravarty, MD
Division of Immunology & Rheumatology
Stanford University
School of Medicine
Stanford, California

Marla C. Dubinsky, MD
Pediatric Inflammatory Bowel Disease Program
Cedars-Sinai Medical Center
Los Angeles, California

Helen Emery, MB, BS
Division of Pediatric Rheumatology
Seattle Children’s Hospital
University of Washington
Seattle, Washington

Sonia Friedman, MD, FACG
Division of Gastroenterology, Hepatology and Endoscopy
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts

Alexa Boer Kimball, MD, MPH
Department of Dermatology
Massachusetts General Hospital
Harvard University
Boston, Massachusetts

Daniela Kroshinsky, MD
Department of Dermatology
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Kim L. Isaacs, MD, PhD
Division of Gastroenterology and Hepatology
University of North Carolina
Chapel Hill, North Carolina

Neil Silverman, MD
Department of Obstetrics & Gynecology,
Division of Maternal-Fetal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Vibeke Strand, MD, FACP, FACR
Division of Immunology & Rheumatology
Stanford University
School of Medicine
Palo Alto, California

Abby Van Voorhees, MD
Department of Dermatology
University of Pennsylvania
Philadelphia, Pennsylvania

 

8:00 am
Breakfast and registration

8:30 am
Introductions and objectives
Marla C. Dubinsky, MD
Alexa Boer Kimball, MD, MPH
Neil Silverman, MD
Vibeke Strand, MD, FACP, FACR

8:40 am
Pre-session audience response survey

8:45 am
The Young and the Restless: A case-based approach to growth, medication risk, and transition of care
Marla C. Dubinsky, MD
Helen Emery, MB, BS
Daniela Kroshinsky, MD

9:35 am
Q&A with panel discussion: Are children just little adults?
Moderator
Marla C. Dubinsky, MD

Panelists
Helen Emery, MB, BS
Daniela Kroshinsky, MD

9:50 am
Healthcare maintenance for immune
disorders: An update on vaccinations, bone monitoring, and cancer screening
Sonia Friedman, MD

10:15 am
Post-session audience response survey

10:20 am
Break

10:35 am
Pre-session audience response survey

10:40 am
Quality of life and social connectivity for women: A comparison across immune disorders
Alexa Boer Kimball, MD, MPH

11:20 am
Q&A with panel discussion: Maintaining health and quality of life
Moderator
Alexa Boer Kimball, MD, MPH

Panelists
Kim L. Issacs, MD, PhD
Sonia Friedman, MD

11:40 am
Emerging risks in women with immune disorders: Understanding premature cardiovascular disease
and malignancy
Vibeke Strand, MD, FACP, FACR

12:00 pm
Putting risk into perspective: A case-based discussion
Moderator
Vibeke Strand, MD, FACP, FACR

Panelists
Abby Van Voorhees, MD
Kim L. Issacs, MD, PhD

12:25 pm
Post-session audience response survey

12:30 pm
Lunch

1:15 pm
Pre-session audience response survey

1:20 pm
Fertility and pregnancy: The impact of chronic immune disorders and treatments
Eliza Chakravarty, MD

1:50 pm
Perinatal considerations and teratogenicity counseling
Neil Silverman, MD

2:20 pm
Q&A with panel discussion: Managing patient’s expectations on pregnancy
Moderator
Neil Silverman, MD

Panelists
Eliza Chakravarty, MD
Sonia Friedman, MD

2:50 pm
Post-session audience response survey

2:55 pm
Summary and concluding remarks
Marla C. Dubinsky, MD
Alexa Boer Kimball, MD, MPH
Neil Silverman, MD
Vibeke Strand, MD, FACP, FACR

3:00 pm
Adjourn

Information coming soon.

This is a complimentary educational meeting for physicians and nurses. There is no cost to attend this activity or to obtain CME credits.

Register Now

The Westin New York at Times Square
270 West 43rd Street
New York, New York 10036
Tel: +1 (212) 201 2700
Fax: +1 (212) 201 2701
www.westinny.com

For the convenience of attendees, a room block with a limited number of rooms has been reserved at the discounted group rate of $299 single/$319 double occupancy, plus tax, currently at 14.75% plus a $3.50 New York City Occupancy Tax/Javits Center Fee. This limited number of discounted rooms will be available until September 3, 2010. This discounted rate is not guaranteed outside the conference dates. Reservations received after September 3, 2010 or after the room block has been filled (whichever comes first) are subject to availability and prevailing hotel rates.

To reserve your room please contact the The Westin New York at Times Square reservations department at +1 (212) 201 2700 or visit the hotel’s website at www.westinny.com. To receive the group rate, callers must identify themselves as being with the Imedex/The Management of Women with Chronic Immune Disorders in the Era of Biologics group. Reservation requests received after September 3, 2010 may not be guaranteed the group rate.

Letter from the Chairs

Dear Colleague,
It is with great pleasure that we invite you to New York for the 2nd annual Management of Women with Chronic Immune Disorders in the Era of Biologics conference to be held September 25, 2010. This unique conference will focus on the impact of biological agents and novel drug therapies on the treatment of chronic immune disorders in women - including inflammatory bowel disease, psoriasis, and rheumatoid arthritis.

This one day educational event will include presentations by nationally recognized faculty as well as lively interaction via expert-moderated panel discussions. Clinicians across multiple disciplines will be able to benefit from these case-based discussions on challenges and controversies currently surrounding chronic immune disorders. Attendees can expect to leave this conference with not only a greater understanding of how to use biologics safely and with improved patient outcomes but more importantly, better insight into how the presence and management of this group of diseases can impact women from adolescence to adulthood, throughout pregnancy, and entering menopause. These quality of life and social issues are common concerns for female patients and are just as important in determining optimal treatment and management of chronic immune disorders.

Please join us in New York for what promises to be a rewarding and highly educational experience.

Sincerely,
Marla C. Dubinsky, MD
Alexa Boer Kimball, MD, MPH
Neil S. Silverman, MD
Vibeke Strand, MD


Organizer

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

PDF Announcement




This activity is endorsed by the following societies, associations, and foundations:

ACG
AGA
New York County Medical Society
New York County
Medical Society

We Care

The following companies have provided an educational grant in support of this conference:

GOLD


Abbott

Amgen

Centocor Inc

 

Several options are available to companies interested in supporting this conference.
For more information, please contact Imedex at +1 (770) 751 7332, or by email at cme@imedex.com.

Information coming soon.

Opportunities are available to companies interested in exhibiting at this conference.
For more information, please contact Cori Gunter at +1 (678) 242 0712, or by email at c.gunter@imedex.com.